The simulations show that in the case where anti-VEGF decreases the perfusion of the anti-PD-1, the time it takes to reduce tumor volume by 95% is much shorter when the injections of the two drugs are non-overlapping than when the injections are given at the same time. Here, PDCD1 is linked to neoplasm.